These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38872374)

  • 1. Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists.
    Fernandez M; Pezier T; Papadopoulos S; Laurent F; Werts C; Lacroix-Lamandé S
    J Leukoc Biol; 2024 Jun; ():. PubMed ID: 38872374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and
    Choteau L; Vancraeyneste H; Le Roy D; Dubuquoy L; Romani L; Jouault T; Poulain D; Sendid B; Calandra T; Roger T; Jawhara S
    Gut Pathog; 2017; 9():9. PubMed ID: 28289440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
    Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
    J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.
    Chang S; Dolganiuc A; Szabo G
    J Leukoc Biol; 2007 Sep; 82(3):479-87. PubMed ID: 17595379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes.
    Oosting M; Ter Hofstede H; Sturm P; Adema GJ; Kullberg BJ; van der Meer JW; Netea MG; Joosten LA
    PLoS One; 2011; 6(10):e25998. PubMed ID: 21998742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsid proteins of foot-and-mouth disease virus interact with TLR2 and CD14 to induce cytokine production.
    Lin YT; Chen YP; Fang CH; Huang PY; Liang SM
    Immunol Lett; 2020 Jul; 223():10-16. PubMed ID: 32333963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists.
    Curtiss LK; Black AS; Bonnet DJ; Tobias PS
    J Lipid Res; 2012 Oct; 53(10):2126-2132. PubMed ID: 22822027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling.
    Guan Y; Ranoa DR; Jiang S; Mutha SK; Li X; Baudry J; Tapping RI
    J Immunol; 2010 May; 184(9):5094-103. PubMed ID: 20348427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial and stromal cells of bovine endometrium have roles in innate immunity and initiate inflammatory responses to bacterial lipopeptides in vitro via Toll-like receptors TLR2, TLR1, and TLR6.
    Turner ML; Cronin JG; Healey GD; Sheldon IM
    Endocrinology; 2014 Apr; 155(4):1453-65. PubMed ID: 24437488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.
    Ozinsky A; Underhill DM; Fontenot JD; Hajjar AM; Smith KD; Wilson CB; Schroeder L; Aderem A
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13766-71. PubMed ID: 11095740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
    Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis for recognition of bacterial ligands at equine TLR2, TLR1 and TLR6.
    Irvine KL; Hopkins LJ; Gangloff M; Bryant CE
    Vet Res; 2013 Jul; 44(1):50. PubMed ID: 23826682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of MBL2, TLR1, TLR2 and TLR6 Polymorphisms With Production of IFN-γ and IL-12 in BCG Osteitis Survivors R1.
    Pöyhönen L; Kröger L; Huhtala H; Mäkinen J; Nuolivirta K; Mertsola J; He Q; Korppi M
    Pediatr Infect Dis J; 2017 Feb; 36(2):135-139. PubMed ID: 27755461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell membrane-bound toll-like receptor-1/2/4/6 monomers and -2 heterodimer inhibit enterovirus 71 replication by activating the antiviral innate response.
    Sun PP; Li D; Su M; Ren Q; Guo WP; Wang JL; Du LY; Xie GC
    Front Immunol; 2023; 14():1187035. PubMed ID: 37207203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.
    Farhat K; Riekenberg S; Heine H; Debarry J; Lang R; Mages J; Buwitt-Beckmann U; Röschmann K; Jung G; Wiesmüller KH; Ulmer AJ
    J Leukoc Biol; 2008 Mar; 83(3):692-701. PubMed ID: 18056480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sperm activate TLR2/TLR1 heterodimerization to induce a weak proinflammatory response in the bovine uterus.
    Mansouri A; Yousef MS; Kowsar R; Usui N; Akthar I; Miyamoto A
    Front Immunol; 2023; 14():1158090. PubMed ID: 37180107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
    Nishiya T; DeFranco AL
    J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of lipopeptides by Toll-like receptors.
    Takeda K; Takeuchi O; Akira S
    J Endotoxin Res; 2002; 8(6):459-63. PubMed ID: 12697090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions.
    Parra-Izquierdo I; Lakshmanan HHS; Melrose AR; Pang J; Zheng TJ; Jordan KR; Reitsma SE; McCarty OJT; Aslan JE
    Front Immunol; 2021; 12():729951. PubMed ID: 34527000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
    Rajalakshmy AR; Malathi J; Madhavan HN
    PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.